SEARCH BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 104,323 |
| Revenue | 51.8B USD (2024) |
Novartis is a healthcare and pharmaceutical enterprise dedicated to advancing medical innovation and enhancing patient well-being. Renowned for its pioneering research and development efforts, Novartis has a comprehensive portfolio encompassing groundbreaking pharmaceuticals, generic medications, biosimilars, and eye care solutions. Novartis was founded in 1996 and is based in Basel, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 36 |
| Sector: Life Science M&A | 26 of 30 |
| Type: Add-on Acquisition M&A Deals | 27 of 30 |
| Country: Germany M&A | 1 of 1 |
| Year: 2024 M&A | 2 of 4 |
| Size (of disclosed) | 4 of 20 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-05 |
SanReno Therapeutics
Shanghai, China SanReno Therapeutics is a clinical-stage enterprise specializing in the strategic development, exploration, and commercialization of revolutionary therapies tailored for kidney diseases. The company's key assets focus on treating Immunoglobulin A Nephropathy (IgAN). Atrasentan, an oral endothelian A receptor antagonist (ERA), has reached Phase 3 with success in reducing proteinuria. Zigakibart, its anti-APRIL (A Proliferation Inducing Ligand) antibody, received regulatory approval for Phase 3 studies. SanReno Therapeutics is based in Shanghai. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-05-02 |
Mariana Oncology
Watertown, Massachusetts, United States Mariana Oncology is a fully integrated, radiopharmaceutical company pioneering a new standard of care in cancer treatment targeted peptide-based radioligand therapeutics (RLTs) designed to maximize tumor penetration while minimizing toxicity. Mariana Oncology is based in Watertown, Massachusetts. |
Buy | $1.0B |
